Name: Global Flu Vaccine Market Research Report 2023-2030
Brand: Global Flu Vaccine Market Research Report 2023-2030
Price: 3699 USD
Availability: InStock

Global Flu Vaccine Market Research Report 2023-2030

Report ID : 1386 | Publisher ID : Biz | Published : Apr-2023 | Pages : 175

The 2023 global report on the Flu Vaccine market presents a comprehensive and descriptive analysis of key players who have made significant contributions to the global market. Flu Vaccine market was valued at 7.7 billion US$ in 2022 and is projected to reach 15.5 billion US$ by 2030, at a CAGR of 9.1% during the forecast period. A flu vaccine is a vaccine that is used to protect against infection with influenza viruses. The flu is a respiratory illness caused by the influenza virus that can lead to severe symptoms, hospitalization, and even death, particularly in vulnerable populations such as older adults, young children, and people with certain underlying health conditions. There are two main types of flu vaccines: inactivated (killed) flu vaccines and live attenuated flu vaccines. Inactivated flu vaccines are made from inactivated (dead) influenza viruses and are given as a shot. Live attenuated flu vaccines are made from live, but weakened influenza viruses and are given as a nasal spray. Flu vaccines are typically given annually to provide protection against the strains of influenza virus that are expected to circulate in the upcoming flu season. The intelligence report on the global Flu Vaccine market provides deep analysis of the Flu Vaccine industry segments including product Vaccine Type, Type, special geographies and elite vendors. Key Driving Factors of the Market • A high incidence or frequency of influenza • An increase in the attention and resources dedicated to immunization programs by government authorities Key Restraints of the Market • Lengthier periods of time and the implementation of strict regulations • Expensive costs associated with the deployment of vaccines. Key Opportunity of the Market • Growth prospects in emerging markets Global Flu Vaccine Market Segmentation Leading Competitors of the Market 2023 Abbott AstraZeneca Astrazeneca Plc BIKEN Co, Ltd Biodiem CSL Limited Csl Limited (Seqirus GmbH) Emergent Biosolutions F. Hoffmann-La Roche Ltd. Gamma Vaccines Pty Ltd. Glaxosmithkline Plc Merck & Co., Inc. (Merck Sharp & Dohme Corp.) Novartis Ag Pfizer, Inc. Sanofi Sinovac Biotech Ltd. Viatris Inc Market Segmentation by Vaccine Type Quadrivalent Trivalent Market Segmentation by Type Seasonal Pandemic Outlook 2023-2030: Global Flu Vaccine Market: The latest report on the global Flu Vaccine market is liable to deliver Flu Vaccine industry size, pricing trends, share and forecast evaluation in details. This systematic and professional study concentrates on the current state of the global Flu Vaccine market, highlights competitive scenarios, supply and demand conditions, opportunities, and potential threats faced by key players, along with the challenges that drive the global Flu Vaccine market growth. Regional Analysis: Global Flu Vaccine Market 2023 The report encompasses major regions as North America, Europe, Asia Pacific, South America ,and Middle East & Africa. Our researchers have employed primary and secondary research methods, as well as other advanced tools, to generate an accurate and informative report on the Flu Vaccine market. In addition, we have utilized both qualitative and quantitative techniques to provide a comprehensive explanation of every aspect of the Flu Vaccine market.